National Cancer Institute; Notice of Closed Meetings, 4276-4277 [07-365]
Download as PDF
4276
Federal Register / Vol. 72, No. 19 / Tuesday, January 30, 2007 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Description of Technology: Cystic
fibrosis (CF) is a common genetic
disease that affects the entire body,
producing thick, sticky mucus that clogs
the lungs, pancreas, and other organs. It
is the most common fatal genetic
disease in the United States, and is
caused by a mutation in the cystic
fibrosis transmembrane conductance
regulator (CFTR).
Researchers at NIEHS have developed
a cell line, CF/T43, which was produced
by infection of airway epithelial cells
isolated from CF patients with an
SV40T retrovirus. CF/T43 cells maintain
the abnormal ion transport
characteristics of CF while having
proliferation capability beyond that of a
primary epithelial cell culture. Key
features of the CF/T43 cell line include
the formation of functional tight
junctions, reduced apical membrane
chloride conductance, and activation of
apical chloride channels by calcium
ionophores but not by cAMP-dependent
agonists. This cell line may be used for
elucidation of the mechanisms of CF,
testing candidate complementary genes
for correction of the observed CF
abnormalities, and for developing and
testing therapeutic CF drugs.
Applications: Research tool for
developing new therapies to treat cystic
fibrosis; Research tool for studying the
mechanisms of cystic fibrosis.
Inventors: Anton M. Jetten (NIEHS).
Publication: AM Jetten, JR Yankaskas,
MJ Stutts, NJ Willumsen, and RC
Boucher. Persistence of abnormal
chloride conductance regulation in
SV40 T transformed cystic fibrosis
airway epithelia. Science 1989 Jun
23;244(4911):1472–1475.
Patent Status: U.S. Patent Application
No. 07/368,725 filed 21 June 1989,
which issued as U.S. Patent No.
5,420,033 on 30 May 1995 (HHS
Reference No. E–201–1989/0–US–01).
Licensing Status: Available for
exclusive or nonexclusive licensing.
Licensing Contact: Tara Kirby, Ph.D.;
301/435–4426; tarak@mail.nih.gov.
ycherry on PROD1PC64 with NOTICES
Epithelial Cell Line Expressing a Cystic
Fibrosis Phenotype
National Institutes of Health
Dated: January 20, 2007.
Steven M. Ferguson,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. E7–1379 Filed 1–29–07; 8:45 am]
BILLING CODE 4140–01–P
VerDate Aug<31>2005
15:36 Jan 29, 2007
Jkt 211001
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5.
U.S.C., as amended. The grant
applications and/or contact proposals
and the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, R25
Special Emphasis Panel.
Date: February 6, 2007.
Time: 5 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Washington Court Hotel, 525 New
Jersey Ave, NW., Washington, DC 20001.
Contact Person: David E. Maslow, PhD.,
Chief, Resources and Training Review
Branch, Division of Extramural Activities,
National Cancer Institute, National Institutes
of Health, 6116 Executive Boulevard—Room
8117, Bethesda, MD 20892–7405, (301) 496–
2330.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Arrays for
Biomarker.
Date: February 13, 2007.
Time: 12 p.m. to 6 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6116
Executive Boulevard, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Lalita D. Palekar, PhD,
Scientific Review Administrator, Special
Review and Resources Branch, Division of
Extramural Activities, National Cancer
Institute, National Institutes of Health, 6116
Executive Boulevard, Room 8105, Bethesda,
MD 20892–7405, (301) 496–7575.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Multiplex
Affinity Capture Technology.
Date: February 15, 2007.
Time: 12 p.m. to 6 p.m.
Agenda: To review and evaluate contract
proposals.
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
Place: National Institutes of Health, 6116
Executive Boulevard, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Lalita D. Palekar, PhD,
Scientific Review Administrator, Special
Review and Resources Branch, Division of
Extramural Activities, National Cancer
Institute, National Institutes of Health, 6116
Executive Boulevard, Room 8105, Bethesda,
MD 20892–7405, (301) 496–7575.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Manpower
and Training Grants.
Date: February 27–28, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Old Town Alexandria, 1767
King Street, Alexandria, VA 22314.
Contact Person: Lynn M Amende, PhD,
Scientific Review Administrator, Resources
and Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Boulevard Room
8105, Bethesda, MD 20892–8328, 301–451–
4759, amendel@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Small
Grants Program for Cancer Epidemiology and
Cancer Prevention Research.
Date: March 6–8, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Georgetown, 2101
Wisconsin Avenue, NW., Washington, DC
20007.
Contact Person: Irina Gordienko, PhD,
Scientific Review Administrator, Special
Review and Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Blvd., Rm.
703, MS 2829, Bethesda, MD 20892, 301–
594–1566, gordienoiv@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, AntiCancer Agents.
Date: March 15, 2007.
Time: 11 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health Events
Management, Executive Plaza North
Conference Center, 6130 Executive
Boulevard, Conference Room D, Rockville,
MD 20852, (Telephone Conference Call).
Contact Person: Jeannette F Korczak, PhD,
Scientific Review Administrator, Resources
and Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Blvd., Room
8115, Bethesda, MD 20892, 301–496–9767,
korczakj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
E:\FR\FM\30JAN1.SGM
30JAN1
Federal Register / Vol. 72, No. 19 / Tuesday, January 30, 2007 / Notices
Dated: January 21, 2007.
David Clary,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–365 Filed 1–29–07; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Nursing Research;
Notice of Closed Meeting
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
ycherry on PROD1PC64 with NOTICES
Name of Committee: Minority Programs
Review Committee, MARC Review
Subcommittee A.
Date: February 15, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin Ave.,
Bethesda, MD 20814.
Contact Person: Mona R. Trempe, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, 45 Center Drive, Room 3AN12,
Bethesda, MD 20892, 301–594–3998,
trempemo@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: January 21, 2007.
David Clary,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–358 Filed 1–29–07; 8:45 am]
BILLING CODE 4140–01–M
VerDate Aug<31>2005
15:36 Jan 29, 2007
Jkt 211001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Nursing Research Special Emphasis Panel,
Mentored Research Scientist Development
Award.
Date: March 5, 2007.
Time: 7:30 a.m. to 8 a.m.
Agenda: To review and evaluate grant
applications.
Place: Crowne Plaza Hotel, 8777 Georgia
Avenue, Silver Spring, MD 20910.
Contact Person: John E. Richters, PhD,
Chief, Office of Review, Division of
Extramural Activities, National Institute of
Nursing Research, National Institutes of
Health, 6701 Democracy Blvd. Room 715,
Bethesda, MD 20817, (301) 594–5971,
jrichters@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.361, Nursing Research,
National Institutes of Health, HHS)
Dated: January 21, 2007.
David Clary,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–359 Filed 1–29–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of of Nursing
Research; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
4277
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Nursing Research Special Emphasis Panel,
RFA–NR–07–002/3: Culturally Appropriate
Research to Prevent HIV Transmission.
Date: March 14–15, 2007.
Time: 8 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crowne Plaza Hotel, 8777 Georgia
Avenue, Silver Spring, MD 20910.
Contact Person: John E. Richters, PhD,
Chief, Office of Review, Division of
Extramural Activities, National Institute of
Nursing Research, National Institutes of
Health, 6701 Democracy Blvd. Room 715,
Bethesda, MD 20817, (301) 594–5971,
jrichters@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.361, Nursing Research,
National Institutes of Health, HHS)
Dated: January 21, 2007.
David Clary,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–360 Filed 1–29–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Communication
Disorders Review Committee, CDRC.
Date: February 15–16, 2007.
Time: February 15, 2007, 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\30JAN1.SGM
30JAN1
Agencies
[Federal Register Volume 72, Number 19 (Tuesday, January 30, 2007)]
[Notices]
[Pages 4276-4277]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-365]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5.
U.S.C., as amended. The grant applications and/or contact proposals and
the discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications and/or
contract proposals, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel, R25 Special Emphasis Panel.
Date: February 6, 2007.
Time: 5 p.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Washington Court Hotel, 525 New Jersey Ave, NW.,
Washington, DC 20001.
Contact Person: David E. Maslow, PhD., Chief, Resources and
Training Review Branch, Division of Extramural Activities, National
Cancer Institute, National Institutes of Health, 6116 Executive
Boulevard--Room 8117, Bethesda, MD 20892-7405, (301) 496-2330.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Cancer Institute Special Emphasis
Panel, Arrays for Biomarker.
Date: February 13, 2007.
Time: 12 p.m. to 6 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6116 Executive Boulevard,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Lalita D. Palekar, PhD, Scientific Review
Administrator, Special Review and Resources Branch, Division of
Extramural Activities, National Cancer Institute, National
Institutes of Health, 6116 Executive Boulevard, Room 8105, Bethesda,
MD 20892-7405, (301) 496-7575.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Multiplex Affinity Capture Technology.
Date: February 15, 2007.
Time: 12 p.m. to 6 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6116 Executive Boulevard,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Lalita D. Palekar, PhD, Scientific Review
Administrator, Special Review and Resources Branch, Division of
Extramural Activities, National Cancer Institute, National
Institutes of Health, 6116 Executive Boulevard, Room 8105, Bethesda,
MD 20892-7405, (301) 496-7575.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Manpower and Training Grants.
Date: February 27-28, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Old Town Alexandria, 1767 King Street, Alexandria,
VA 22314.
Contact Person: Lynn M Amende, PhD, Scientific Review
Administrator, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, 6116 Executive
Boulevard Room 8105, Bethesda, MD 20892-8328, 301-451-4759,
amendel@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Small Grants Program for Cancer Epidemiology and Cancer
Prevention Research.
Date: March 6-8, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Holiday Inn Georgetown, 2101 Wisconsin Avenue, NW.,
Washington, DC 20007.
Contact Person: Irina Gordienko, PhD, Scientific Review
Administrator, Special Review and Logistics Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 6116
Executive Blvd., Rm. 703, MS 2829, Bethesda, MD 20892, 301-594-1566,
gordienoiv@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel, Anti-Cancer Agents.
Date: March 15, 2007.
Time: 11 a.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health Events Management,
Executive Plaza North Conference Center, 6130 Executive Boulevard,
Conference Room D, Rockville, MD 20852, (Telephone Conference Call).
Contact Person: Jeannette F Korczak, PhD, Scientific Review
Administrator, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 6116
Executive Blvd., Room 8115, Bethesda, MD 20892, 301-496-9767,
korczakj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
[[Page 4277]]
Dated: January 21, 2007.
David Clary,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-365 Filed 1-29-07; 8:45 am]
BILLING CODE 4140-01-M